Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision (v3.4.2) was added and older v3.4.1 funding-status notices were removed. These updates are maintenance-related and do not alter study information or user interaction on the page.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center operations, with guidance to check opm.gov for status updates. Updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a Show glossary toggle and updated QC metadata (Last Update Submitted that Met QC Criteria) with Revision: v3.4.0, while removing the prior lowercase label, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page footer. This is a minor site update and does not change the study details or user-facing content.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations are now listed under a single Locations section with sites across US states and Canadian provinces; the page shows a Revision: v3.3.3.SummaryDifference2%

- Check86 days agoChange DetectedRevision: v3.3.2 has been added and the previous v3.3.1 revision has been removed.SummaryDifference0.0%

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.